Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
acute, adenocarcinoma, Aduro, analyst, Aptar, arisen, artificially, assumption, automated, Baltimore, BLOOM, BMS, Book, brokerage, budgeted, buy, caption, carefully, catastrophic, compromised, consummation, contractor, coordination, customer, defense, disappoint, disrupt, disruption, dissemination, distributor, District, endpoint, entirety, equitable, expert, expressly, facilitate, facilitating, false, Foundation, furniture, grace, headcount, Hussman, Ib, imply, incurrence, intangible, IPI, ipilimumab, Jazz, Language, Lauria, lifted, Listeria, Lm, machinery, Maryland, meantime, melanoma, metastatic, mid, milliliter, misleading, multicenter, myeloid, Northern, notification, null, Orange, overwhelming, path, PDA, penny, pharmacokinetic, pice, platform, purported, realistic, reallocate, reallocating, redundancy, regain, reluctant, repaid, repayment, reverse, secondary, shift, situated, split, strongly, suburb, suburban, supplier, supposed, uncured, Underwriting, underwritten, unfavorable, unspecified, unwaived, VaxOnco, viable, vigorously, Yervoy
Removed:
adjustable, aesthetic, antibody, auction, billion, biolook, bulletin, calcium, California, cancelled, cap, CEFF, chosen, confirmed, continuation, derivative, electronic, enrolling, equaled, Europe, expiring, facial, filler, finalized, friendly, grew, injectable, interpreting, IRS, Japan, launched, MATC, met, nanotechnology, naturally, notified, OTC, permissible, phosphate, Pink, plc, positive, prescribing, protein, recruitment, reducing, registering, reinitiated, removed, sample, serve, solid, spending, susceptible, uniform, unlisted, validated, work
Filing tables
Filing exhibits
Related press release
ANIP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-174596, 333-168842, 333-151663, 333-151660, 333-109474, 333-100238 and 333-53384 on Form S-8 and in Registration Statement Nos. 333-156276, 333-174597, 333-166859, 333-159606 and 333-64218 on Form S-3 of our reports dated March 13, 2012, relating to the financial statements of BioSante Pharmaceuticals, Inc., and the effectiveness of BioSante Pharmaceuticals Inc.’s internal control over financial reporting, appearing in this Annual Report on Form 10-K of BioSante Pharmaceuticals, Inc. for the year ended December 31, 2011.
/s/ DELOITTE & TOUCHE LLP |
|
|
|
Chicago, Illinois |
|
|
|
March 13, 2012 |
|